MY127600A - Solid oral dosage forms of valsartan - Google Patents

Solid oral dosage forms of valsartan

Info

Publication number
MY127600A
MY127600A MYPI0401893A MY127600A MY 127600 A MY127600 A MY 127600A MY PI0401893 A MYPI0401893 A MY PI0401893A MY 127600 A MY127600 A MY 127600A
Authority
MY
Malaysia
Prior art keywords
dosage forms
oral dosage
solid oral
valsartan
concerned
Prior art date
Application number
Inventor
Robert Frank Wagner
Yoshimitsu Katakuse
Takashi Taike
Fujiki Yamato
Manfred Dr Kohlmeyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority to MYPI0401893 priority Critical patent/MY127600A/en
Publication of MY127600A publication Critical patent/MY127600A/en

Links

Abstract

THE PRESENT INVENTION IS CONCERNED WITH SOLID ORAL DOSAGE FORMS OF COMPRISING (A) AN ACTIVE AGENT SELECTED FROM VALSARTAN AND OPTIONALLY HCTZ, AND (B) PHARMACEUTICALLY ACCEPTABLE ADDITIVES SUITABLE FOR THE PREPARATION OF SOLID ORAL DOSAGE FORMS BY COMPRESSION METHODS.
MYPI0401893 1997-06-14 1997-06-14 Solid oral dosage forms of valsartan MY127600A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI0401893 MY127600A (en) 1997-06-14 1997-06-14 Solid oral dosage forms of valsartan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI0401893 MY127600A (en) 1997-06-14 1997-06-14 Solid oral dosage forms of valsartan

Publications (1)

Publication Number Publication Date
MY127600A true MY127600A (en) 2006-12-29

Family

ID=47264663

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI0401893 MY127600A (en) 1997-06-14 1997-06-14 Solid oral dosage forms of valsartan

Country Status (1)

Country Link
MY (1) MY127600A (en)

Similar Documents

Publication Publication Date Title
MY123149A (en) Solid oral dosage forms of valsartan
YU39400A (en) Opioid agonist/antagonist combinations
PT893992E (en) FORMS OF FAST DISINTEGRATION ORAL DOSAGE
IL160222A0 (en) Opioid agonist formulations with releasable and sequestered antagonist
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
NZ514574A (en) Novel method of treatment
RU2008143545A (en) APPLICATION OF AT-1 RECEPTOR ANTAGONIST OR AT-2 RECEPTOR MODULATOR FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASING THE CONTENT OF AT-1 OR AT-2 RECEPTORS
WO1995031985A3 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
SG188700A1 (en) Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
MY118569A (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
AU674379B2 (en) Antitussive
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
MY127600A (en) Solid oral dosage forms of valsartan
UA32598C2 (en) Method for obtaining of carbamazepin dosage form
ECSP972162A (en) SOLID ORAL DOSAGE FORMS CONTAINING VALSARTAN
MX9606041A (en) Fast dissolving dosage forms.